The TGA has approved Gedeon Richter's RYEQO (relugolix, estradiol, norethisterone acetate) to treat endometriosis symptoms.
Gedeon Richter welcomes TGA approval of endometriosis treatment
February 23, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Internal promotions for new generation of leaders at Astellas
May 7, 2025 - - Latest News -
New study reveals the far-reaching impact of ovarian cancer
May 7, 2025 - - Latest News -
Just the threat of tariffs has secured a quarter of a trillion in investment
May 7, 2025 - - Latest News -
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech -
OncoSil Medical reports positive results of pancreatic cancer analysis
May 7, 2025 - - Australian Biotech -
Europe warned to adopt positive changes in response to US investment rush
May 7, 2025 - - Latest News -
CLINUVEL recruits 200 patients for Phase 3 vitiligo trial of SCENESSE
May 7, 2025 - - Australian Biotech